Acute chest syndrome and other pulmonary manifestations of sickle cell disease

Journal of Clinical Outcomes Management

Volumn 18, Issue 5, 2011, Pages 211-221

  Hirani, Amyn ^a   Weibel, Sandra ^a   Kane, Gregory C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ARGININE; BRONCHODILATING AGENT; CORTICOSTEROID; HYDROXYUREA; NITRIC OXIDE; PENICILLIN V; PNEUMOCOCCUS VACCINE; POLOXAMER; TINZAPARIN;

ACUTE CHEST SYNDROME; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BREATHING; BRONCHOSPASM; DISEASE EXACERBATION; HUMAN; HYDRATION; HYPOXIA; INTERSTITIAL LUNG DISEASE; LUNG COMPLICATION; MORBIDITY; MORTALITY; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; REVIEW; SICKLE CELL ANEMIA; SPIROMETRY; THROMBOEMBOLISM; TREATMENT INDICATION;

EID: 79957454456     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review. Am J Epidemiol 2000;151:839-45. (Pubitemid 30461125)
2. Paixão MC, Cunha Ferraz MH, Januário JN, et al. Reliability of isoelectrofocusing for the detection of Hb S, Hb C, and HB D in a pioneering population-based program of newborn screening in Brazil. Hemoglobin 2001;25:297-303.
3. Loureiro MM, Rozenfeld S. [Epidemiology of sickle cell disease hospital admissions in Brazil]. [Article in Portuguese]. Rev Saude Publica 2005;39:943-9.
4. Fleming AF. The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Rev 1989;3:18-28. (Pubitemid 19086222)
5. World Health Organization. Sickle cell anemia. Available at www.who.int/genomics/public/geneticdiseases/en/index2.html. Accessed 25 Feb 2011.
6. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med 1979;139:67-9.
7. Powars DR, Chan LS, Hiti A, et al. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 2005;84:363-76. (Pubitemid 41668935)
8. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-9. (Pubitemid 24215969)
9. Ahmed S, Siddiqui AK, Sadiq A, et al. Echocardiographic abnormalities in sickle cell disease. Am J Hematol 2004;76:195-8. (Pubitemid 38828835)
10. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group [published erratum appears in N Engl J Med 2000;343:824]. N Engl J Med 2000;342:1855-65.
11. Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997;89:1787-92. (Pubitemid 27097475)
12. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
13. Brittenham GM, Schechter AN, Noguchi CT. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes. Blood 1985;65:183-9. (Pubitemid 15191056)
14. Ingram VM. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 1957;180:326-8.
15. Setty BN, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 1996;88:2311-20. (Pubitemid 26307936)
16. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 1999;94:1555-60. (Pubitemid 29411305)
17. Castro V, Alberto FL, Costa RN, et al. Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sang 2004;87:118-123. (Pubitemid 39265460)
18. Kirkpatrick MB, Haynes J Jr, Bass JB Jr. Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome. Am J Med 1991;90:206-10.
19. Dean D, Neumayr L, Kelly DM, et al; Acute Chest Syndrome Study Group. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. J Pediatr Hematol Oncol 2003;25:46-55. (Pubitemid 36070964)
20. Bellet PS, Kalinyak KA, Shukla R, et al. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995;333:699-703.
21. Stein PD, Beemath A, Meyers FA, et al. Deep venous thrombosis and pulmonary embolism in hospitalized pa-tients with sickle cell disease. Am J Med 2006;119:897.e7-11.
22. Sylvester KP, Patey RA, Rafferty GF, et al. Airway hyperresponsiveness and acute chest syndrome in children with sickle cell anemia. Pediatr Pulmonol 2007;42:272-6. (Pubitemid 46417701)
23. Nordness ME, Lynn J, Zacharisen MC, et al. Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clin Mol Allergy 2005;3:2.
24. Duckworth L, Hsu L, Feng H, et al. Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms. Pediatr Pulmonol 2007;42:332-8.
25. Boyd JH, Macklin EA, Strunk RC, et al. Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica 2007; 92:1115-18. (Pubitemid 350144219)
26. Platt OS. The acute chest syndrome of sickle cell disease [published erratum appears in N Engl J Med 2000;343:591]. N Engl J Med 2000;342:1904-7. (Pubitemid 30419057)
27. Taylor C, Carter F, Poulose J, et al. Clinical presentation of acute chest syndrome in sickle cell disease. Postgrad Med J 2004;80:346-9. (Pubitemid 38833417)
28. Miller JA, Hinrichs CR. Sickle cell crisis in the adult: chest radiographic findings and comparison with pediatric sickle cell disease. J Natl Med Assoc 2001;93:58-63.
29. Pianosi P, Charge TD, Esseltine DW, Coates AL. Pulse oximetry in sickle cell disease. Arch Dis Child 1993;68:735-8. (Pubitemid 23199856)
30. Ahmed S, Siddiqui AK, Sison CP, et al. Hemoglobin oxy-gen saturation discrepancy using various methods in patients with sickle cell vaso-occlusive painful crisis. Eur J Haematol 2005;74:309-14. (Pubitemid 40461151)
31. Ballas SK, Files B, Luchtman-Jones L, et al. Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin 2006;30:165-70. (Pubitemid 43977317)
32. Naprawa JT, Bonsu BK, Goodman DG, Ranalli MA. Serum biomarkers for identifying acute chest syndrome among patients who have sickle cell disease and present to the emergency department. Pediatrics 2005;116:e420-5.
33. Bargoma EM, Mitsuyoshi JK, Larkin SK, et al. Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome [letter]. Blood 2005;105:3384-5.
34. Lechapt E, Habibi A, Bachir D, et al. Induced sputum versus bronchoalveolar lavage during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 2003;168:1373-7. (Pubitemid 37487334)
35. Godeau B, Schaeffer A, Bachir D, et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med 1996;153:1691-6. (Pubitemid 26142838)
36. Feldman L, Gross R, Garon J, et al. Sickle cell patient with an acute chest syndrome and a negative chest X-ray: potential role of the ventilation and perfusion (V/Q) lung scan. Am J Hematol 2003;74:214-5. (Pubitemid 37368892)
37. Kaur N, Motwani B, Sivasubramaniam D, et al. Potential role of the ventilation and perfusion (V/Q) lung scan in the diagnosis of acute chest syndrome in adults with sickle cell disease. Am J Hematol 2004;77:407-9. (Pubitemid 39578329)
38. Haynes J Jr, Allison RC. Pulmonary edema. Complication in the management of sickle cell pain crisis. Am J Med 1986;80:833-40. (Pubitemid 16033704)
39. Kopecky EA, Jacobson S, Joshi P, Koren G. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clin Pharmacol Ther 2004;75:140-6. (Pubitemid 38324540)
40. Koch J, Manworren R, Clark L, et al. Pilot study of continuous co-infusion of morphine and naloxone in children with sickle cell pain crisis. Am J Hematol 2008;83:728-31.
41. van Beers EJ, van Tuijn CF, Nieuwkerk PT, et al. Patient controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol 2007;82:955-60. (Pubitemid 350004385)
42. Phillips WJ, Gadiraju S, Dickey S, et al. Dexmedetomidine relieves pain associated with acute sickle cell crisis [letter]. J Pain Symptom Manage 2007;34:346-9. (Pubitemid 47446147)
43. Robieux IC, Kellner JD, Coppes MJ, et al. Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation. Pediatr Hematol Oncol 1992;9:317-26.
44. Zipursky A, Robieux IC, Brown EJ, et al. Oxygen therapy in sickle cell disease. Am J Pediatr Hematol Oncol 1992;14:222-8.
45. Bendixen HH, Smith GM, Mead J. Pattern of ventilation in young adults. J Appl Physiol 1964;19:195-8.
46. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood 2006;108:2923-7.
47. Bryant R. Asthma in the pediatric sickle cell patient with acute chest syndrome. J Pediatr Health Care 2005;19:157-62. (Pubitemid 40616271)
48. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev 2007;(2):CD006110.
49. Bernini JC, Rogers ZR, Sandler ES, et al. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998;92:3082-9. (Pubitemid 28492313)
50. Isaacs WA, Effiong CE, Ayeni O. Steroid treatment in the prevention of painful episodes in sickle-cell disease. Lancet 1972;1:570-1.
51. Strouse JJ, Hulbert ML, DeBaun MR, et al. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 2006;118:1916-24. (Pubitemid 46393673)
52. Strouse JJ, Takemoto CM, Keefer JR, et al. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr Blood Cancer 2008;50:1006-12. (Pubitemid 351500179)
53. Firth PG, Tsuruta Y, Kamath Y, et al. Transfusion-related acute lung injury or acute chest syndrome of sickle cell disease? A case report. Can J Anaesth 2003;50:895-9. (Pubitemid 38139534)
54. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993;81:1109-23. (Pubitemid 23067344)
55. Lombardo T, Rosso R, La Ferla A, et al. Acute Chest Syndrome: the role of erythro-exchange in patients with sickle cell disease in Sicily. Transfus Apher Sci 2003;29:39-44. (Pubitemid 36870844)
56. Liem RI, O'Gorman MR, Brown DL. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome. Am J Hematol 2004;76:19-25. (Pubitemid 38579533)
57. Cox JV, Steane E, Cunningham G, et al. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988;148:2485-9.
58. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990;76:1431-7. (Pubitemid 20342762)
59. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37-43.
60. Davies SC, McWilliam AC, Hewitt PE, et al. Red cell alloimmunization in sickle cell disease. Br J Haematol 1986;63:241-5. (Pubitemid 16085856)
61. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-21. (Pubitemid 20171584)
62. Qari MH, Aljaouni SK, Alardawi MS, et al. Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. Thromb Haemost 2007;98:392-6. (Pubitemid 47250243)
63. Ballas SK, Files B, Luchtman-Jones L, et al. Safety of purified poloxamer 188 in sickle cell disease: phase I study of a nonionic surfactant in the management of acute chest syndrome. Hemoglobin 2004;28:85-102. (Pubitemid 38669607)
64. Sullivan KJ, Goodwin SR, Evangelist J, et al. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 1999;27:2563-8.
65. Oppert M, Jörres A, Barckow D, et al. Inhaled nitric oxide for ARDS due to sickle cell disease. Swiss Med Wkly 2004;134:165-7. (Pubitemid 38418936)
66. Al Hajeri A, Serjeant GR, Fedorowicz Z. Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev 2008;(1):CD006957.
67. Weiner DL, Hibberd PL, Betit P, et al. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease [published erratum appears in JAMA 2004;292:925]. JAMA 2003;289:1136-42.
68. Head CA, Swerdlow P, McDade WA, et al. Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis. Am J Hematol 2010; 85:800-2.
69. A prospective, multicenter, double-blind, randomized, placebo-controlled study of nitric oxide for inhalation in the acute treatment of sickle cell pain crisis. Clinical Trials.gov. Available at: http://clinicaltrials.gov/ct2/show/ study/NCT00094887?term=nitric+oxide+and+acute+chest+syndrome&rank=5.
70. Morris CR, Morris SM Jr, Hagar W, et al. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 2003;168:63-9.
71. Scavella A, Leiva L, Monjure H, et al. Effect of L-arginine supplementation on immune responsiveness in patients with sickle cell disease. Pediatr Blood Cancer 2010;55:318-23.
72. Morris CR, Vichinsky EP, van Warmerdam J, et al. Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J Pediatr Hematol Oncol 2003;25:629-34. (Pubitemid 36959424)
73. Trant CA Jr, Casey JR, Hansell D, et al. Successful use of extracorporeal membrane oxygenation in the treatment of acute chest syndrome in a child with severe sickle cell anemia. ASAIO J 1996;42:236-9. (Pubitemid 26169693)
74. Pelidis MA, Kato GJ, Resar LM, et al. Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation. J Pediatr Hematol Oncol 1997;19:459-61. (Pubitemid 28076493)
75. Gillett DS, Gunning KE, Sawicka EH, et al. Life threatening sickle chest syndrome treated with extracorporeal membrane oxygenation. Br Med J (Clin Res Ed) 1987;294:81-2. (Pubitemid 17230087)
76. Raff JP, Dobson CE, Tsai HM. Transfusion of polymerised human haemoglobin in a patient with severe sickle-cell anaemia. Lancet 2002;360:464-5. (Pubitemid 34880148)
77. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106(2 Pt 1):362-6.
78. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 2008;121:562-9.
79. Brun M, Bourdoulous S, Couraud PO, et al. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells. Pharmacogenomics J 2003;3:215-26. (Pubitemid 37160977)
80. Charache S, Terrin ML, Moore RD, et al. Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials 1995;16:432-46. (Pubitemid 26035810)
81. Carache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-22.
82. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment [published erratum appears in JAMA 2003;290:756]. JAMA 2003;289:1645-51.
83. Voskaridou E, Christoulas D, Bilalis A, et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 2010;115:2354-63.
84. Miller ST, Wright E, Abboud M, et al; STOP Investigators. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr 2001;139:785-9. (Pubitemid 34014456)
85. Atkins RC, Walters MC. Haematopoietic cell transplantation in the treatment of sickle cell disease. Expert Opin Biol Ther 2003;3:1215-24. (Pubitemid 38004692)
86. Richards D, Nulsen FE. Angiographic media and the sickling phenomenon. Surg Forum 1971;22:403-4.
87. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350:886-95. (Pubitemid 38252536)
88. Castro O, Hoque M, Brown BD. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood 2003;101:1257-61. (Pubitemid 36182493)
89. Mekontso Dessap A, Leon R, Habibi A, et al. Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 2008;177:646-53. (Pubitemid 351442172)
90. Ataga KI, Moore CG, Jones S, et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol 2006;134:109-15. (Pubitemid 43830036)
91. Ataga KI, Sood N, De Gent G, et al. Pulmonary hypertension in sickle cell disease. Am J Med 2004;117:665-9. (Pubitemid 40288173)
92. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8:1383-9. (Pubitemid 36019423)
93. Rybicki AC, Benjamin LJ. Increased levels of endothelin-1 in plasma of sickle cell anemia patients [letter]. Blood 1998;92:2594-6. (Pubitemid 28453007)
94. Hammerman SI, Kourembanas S, Conca TJ, et al. Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 1997;156:280-5. (Pubitemid 27293202)
95. Machado RF, Anthi A, Steinberg MH, et al; MSH Investigators. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA 2006;296:310-8.
96. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
97. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333:214-21.
98. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
99. Minniti CP, Machado RF, Coles WA, et al. Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease. Br J Haematol 2009;147:737-43.
100. Barst RJ, Mubarak KK, Machado RF, et al. Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies. Br J Haematol 2010;149:426-35.
101. Klings ES, Wyszynski DF, Nolan VG, Steinberg MH. Abnormal pulmonary function in adults with sickle cell anemia. Am J Respir Crit Care Med 2006;173:1264-9. (Pubitemid 43848398)
102. Miller GJ, Serjeant GR. An assessment of lung volumes and gas transfer in sickle-cell anaemia. Thorax 1971;26:309-15.
103. Delclaux C, Zerah-Lancner F, Bachir D, et al. Factors associated with dyspnea in adult patients with sickle cell disease. Chest 2005;128:3336-44. (Pubitemid 41698660)
104. Kaleyias J, Mostofi N, Grant M, et al. Severity of obstructive sleep apnea in children with sickle cell disease. J Pediatr Hematol Oncol 2008;30:659-65.
105. Needleman JP, Franco ME, Varlotta L, et al. Mechanisms of nocturnal oxyhemoglobin desaturation in children and adolescents with sickle cell disease. Pediatr Pulmonol 1999;28:418-22. (Pubitemid 30017561)
106. Hargrave DR, Wade A, Evans JP, et al. Nocturnal oxygen saturation and painful sickle cell crises in children. Blood 2003;101:846-8. (Pubitemid 36139349)